7月以来，诺安多策略、建信灵活配置、中信保诚多策略等大批公募量化基金的单位净值不断创出历史 新高。据Wind统计，截至6月末，超90%的公募量化产品上半年单位净值涨幅为正；创金合信北证50成 份指数增强A/C、诺安多策略A近一年的累计单位净值增长率超100%。"今年以来，A股市场情绪向好， 赛道轮动热点不断，这种结构性行情非常有利于量化产品作出超额收益。"某公募基金量化投资业务负 责人表示。值得注意的是，近期不少公募量化基金经理开始提示小市值股票的回调风险。（中证报） ...

在创新药席卷市场的浪潮中，量化策略基金（包括部分风格类量化策略的主动型基金）正迎来一场静悄悄 而耀眼的"逆袭"。 Wind最新数据显示，全市场有近100只量化策略基金单位净值创历史新高。前十大重仓股占股票持仓比例不到 6%的基金今年更是获得近50%的回报。 近年来，投资者对小市值公司、量化策略等情绪从极度悲观到极度乐观转换过多次。在此类策略赚钱效应再度 火爆之际，市场关于小市值策略是否过热的讨论再度热烈起来。有基金经理表示投资者需要高度关注小市值风 险。 量化策略基金净值频创历史新高 今年以来，人形机器人、创新药等主题轮番上演高弹性大戏，不过仍有不少投资者对此类行业主题型基金的高 波动表示厌恶。但是，让投资者不能视而不见的是，主动型基金赚钱效应已经开始回归。 在创新药主题基金霸屏基金涨幅榜的光芒下，一些主动型基金的最新净值也已经悄然创下历史新高。其中尤以 采取了纯量化策略的基金和部分持仓分散、风格类量化策略的主动型基金居多。 开年以来，A股日均成交额连续维持在万亿元以上，资金回流带动市场活跃度提升，显著优化了量化模型的交 易条件。一些量价因子和统计套利策略在流动性充裕的环境中如鱼得水。 国金量化多因子基金的基 ...

Group 1 - The core viewpoint of the articles highlights the strong performance of Jianxin Fund's products in the first half of 2025, with many ranking in the top 10 of their categories according to Galaxy Securities data [1][2][3] - Jianxin Fund's 18 products have shown outstanding medium to long-term performance, with 7 products ranking in the top 10 across various types including equity, fixed income, index, and commodity [1] - The A-share market experienced a rebound, with the Shanghai Composite Index surpassing 3400 points, driven by strong performances in technology and pharmaceutical sectors, particularly in AI and innovative drugs [1] Group 2 - Jianxin Electronic Industry Stock Fund focuses on three main directions: domestic production, technological innovation, and economic cycles, successfully capturing opportunities in the AI technology wave [2] - Jianxin Flexible Allocation Fund, utilizing a proprietary quantitative multi-factor model, has achieved impressive rankings in its category over 1, 2, and 3 years, placing 3rd, 6th, and 13th respectively [2] - Jianxin Healthcare Mixed Fund has demonstrated strong long-term performance, ranking 4th and 1st in its category over 7 and 10 years respectively [2] Group 3 - Other product types, such as Jianxin Shanghai Gold ETF and Jianxin Short-Duration Pure Bond Fund, have also performed well, with the former leading its category and the latter ranking 2nd over 5 years [3] - The rise in gold prices, supported by global central bank purchases and overseas uncertainties, has positively impacted the performance of Jianxin Shanghai Gold ETF [3] - Jianxin Fund has been actively responding to industry demands for high-quality development, enhancing its investment management capabilities while focusing on key sectors like technology, healthcare, and electronics [3]

Group 1 - The core viewpoint of the articles highlights the strong performance of innovation drug-themed funds, with the Huatai-PineBridge Hong Kong Advantage Select Fund leading the pack with a return of 89.15% as of June 29, 2023 [2][3] - A total of 40 funds have achieved a return exceeding 50% this year, with 16 out of the top 20 funds being innovation drug-themed [2][3] - The AI-themed funds have underperformed significantly, with losses exceeding 20% for the bottom-performing funds [1][3] Group 2 - The active equity funds have generally shown a recovery in performance, with nearly 80% of active equity funds achieving positive returns this year, and over 1,000 funds seeing net value increases of over 10% [4][5] - The market has experienced structural volatility, with different themes impacting fund performance directly, necessitating precise market timing from fund managers [3][4] - The long-term performance of the Huatai-PineBridge North Exchange Innovation Small and Medium Enterprises Select Fund has yielded a cumulative return of 177.04% over the past three years, significantly outperforming its peers [3] Group 3 - The innovation drug sector is currently experiencing a surge, with funds in this category dominating the performance rankings, while the humanoid robot sector has seen a decline from its previous highs [2][7] - The market outlook for the second half of the year suggests a mix of opportunities and risks, with low overall valuation levels and supportive macroeconomic policies being key factors [8][9] - Key investment areas identified include dividend assets, technology sectors with strong policy support, and high-potential domestic demand sectors [9]